Search research articles
Contact Us
Filters
Showing results (181-190 of 1,050) with videos related to
Page
of 105
Sort By:
European Journal of Pharmacology
|
September 17, 1984
Correlation of [3H]5-hydroxytryptamine (5HT) binding to brain stem preparations and the production and prevention of myoclonus in guinea pig by 5HT agonists and antagonists
G Luscombe, P Jenner, C D Marsden
Journal of Neurochemistry
|
July 1, 1985
Evidence that [3H]dopamine is taken up and released from nondopaminergic nerve terminals in the rat substantia nigra in vitro
E Kelly, P Jenner, C D Marsden
Neuroscience Letters
|
May 1, 1985
Lack of effect of intranigral administration of a dopamine analogue, (+/-)-3-(3-hydroxyphenyl)-N,n-propylpiperidine [(+/-)-3-PPP], on nigrostriatal dopamine neurones
E Kelly, P Jenner, C D Marsden
Journal of Neural Transmission. Supplementum
|
January 1, 1988
Receptor changes during chronic dopaminergic stimulation
P Jenner, S Boyce, C D Marsden
Clinical Neuropharmacology
|
April 1, 1997
Strategies for treating patients with advanced Parkinson's disease with disastrous fluctuations and dyskinesias
F Stocchi, G Nordera, C D Marsden
British Journal of Pharmacology
|
May 1, 1979
Evidence for metabolite involvement in bromocryptine-induced circling behaviour [proceedings]
P Jenner, C D Marsden, C Reavill
Neurology
|
August 1, 1979
Cortical reflex myoclonus
M Hallett, D Chadwick, C D Marsden
Life Sciences
|
August 7, 1978
An experimental model of tardive dyskinesias
A Clow, P Jenner, C D Marsden
Neuroscience Letters
|
October 24, 1994
GABAergic modulation of striatal peptide expression in rats and the alterations induced by dopamine antagonist treatment
J Jolkkonen, P Jenner, C D Marsden
British Journal of Pharmacology
|
November 1, 1978
Supersensitivity of cerebral dopamine receptors during on-going chronic (six months) administration of trifluoperazine to rats [proceedings]
A Clow, P Jenner, C D Marsden
Page
of 105
Search research articles
Search
Showing results (181-190 of 1,050) with videos related to
Sort By:
Page
of 105
European Journal of Pharmacology
|
September 17, 1984
Correlation of [3H]5-hydroxytryptamine (5HT) binding to brain stem preparations and the production and prevention of myoclonus in guinea pig by 5HT agonists and antagonists
G Luscombe, P Jenner, C D Marsden
Journal of Neurochemistry
|
July 1, 1985
Evidence that [3H]dopamine is taken up and released from nondopaminergic nerve terminals in the rat substantia nigra in vitro
E Kelly, P Jenner, C D Marsden
Neuroscience Letters
|
May 1, 1985
Lack of effect of intranigral administration of a dopamine analogue, (+/-)-3-(3-hydroxyphenyl)-N,n-propylpiperidine [(+/-)-3-PPP], on nigrostriatal dopamine neurones
E Kelly, P Jenner, C D Marsden
Journal of Neural Transmission. Supplementum
|
January 1, 1988
Receptor changes during chronic dopaminergic stimulation
P Jenner, S Boyce, C D Marsden
Clinical Neuropharmacology
|
April 1, 1997
Strategies for treating patients with advanced Parkinson's disease with disastrous fluctuations and dyskinesias
F Stocchi, G Nordera, C D Marsden
British Journal of Pharmacology
|
May 1, 1979
Evidence for metabolite involvement in bromocryptine-induced circling behaviour [proceedings]
P Jenner, C D Marsden, C Reavill
Neurology
|
August 1, 1979
Cortical reflex myoclonus
M Hallett, D Chadwick, C D Marsden
Life Sciences
|
August 7, 1978
An experimental model of tardive dyskinesias
A Clow, P Jenner, C D Marsden
Neuroscience Letters
|
October 24, 1994
GABAergic modulation of striatal peptide expression in rats and the alterations induced by dopamine antagonist treatment
J Jolkkonen, P Jenner, C D Marsden
British Journal of Pharmacology
|
November 1, 1978
Supersensitivity of cerebral dopamine receptors during on-going chronic (six months) administration of trifluoperazine to rats [proceedings]
A Clow, P Jenner, C D Marsden
Page
of 105